The UK is rightly proud of its pharmaceutical industry. It is a jewel in the crown – a shining beacon of what can be achieved from a blend of intellectual capital and commercial know-how. Our leading pharmaceutical businesses, large and small, are genuine world leaders and a powerful force for societal good.

At one end of the scale, these businesses have become household names: big pharma comprises multi-national organisations operating diversified businesses in global markets. But in addition to these blue chips, the UK is also home to a diverse group of small and medium-sized businesses, often privately-owned, with an impressive track record of their own.

It is these companies – which all too often do not receive the credit they deserve – that the Alantra Pharma Fast 50 seeks to recognise and celebrate. Comprising the 50 fastest-growing privately-owned pharmaceuticals businesses in the UK, the ranking offers an insight into the dynamic, innovative and successful companies underpinning this industry’s success.

The full listing can be found in this month's PharmaTimes here, as well as in our in depth report.